Related Subjects:
|Psychiatric Emergencies
|Depression
|Mania
|Schizophrenia
|Suicide
|Acute Psychosis
|Delusions
|General Anxiety Disorder
|Obsessive-Compulsive disorder
|Wernicke Korsakoff Syndrome
|Medically Unexplained symptoms
|Postpartum/Postnatal Depression
|Postpartum / Postnatal Psychosis
|Eating disorders in Children
π‘ Schizophrenia is a severe mental illness characterised by distortions in thought, perception, and behaviour.
π§ Auditory hallucinations are classic, but remember: olfactory & gustatory hallucinations suggest a neurological cause (e.g. temporal lobe epilepsy).
β οΈ Early recognition, antipsychotic therapy, and psychosocial support dramatically improve outcomes.
π About
- Prevalence ~1% worldwide; onset usually late teensβearly 30s.
- M>F (slightly earlier onset in men, worse prognosis).
- Course: relapsing-remitting, with residual negative symptoms in many patients.
𧬠Aetiology
- π¬ Neurobiology:
- Dopamine hypothesis: β mesolimbic activity β positive symptoms; β mesocortical activity β negative symptoms.
- Structural: enlarged ventricles, reduced temporal + hippocampal volume.
- 𧬠Genetics: Concordance in monozygotic twins ~40β50%.
- π Environment: Urban living, migration, childhood adversity, cannabis use (esp. high potency THC).
- π§ Neurodevelopmental: Obstetric complications, perinatal hypoxia, maternal infection.
β Positive Symptoms
- π§ Hallucinations: typically auditory (βthird-person voicesβ).
- π§© Delusions: persecutory, referential, thought insertion/withdrawal.
- π―οΈ Thought disorder: derailment, neologisms, word salad.
- π€Ή Bizarre behaviour: posturing, agitation, disorganised dress.
β Negative Symptoms
- π Blunted affect & monotone speech.
- πΆ Social withdrawal, self-neglect.
- π Avolition (loss of motivation), anhedonia.
- π£οΈ Alogia (poverty of speech).
π Diagnosis
- ICD-10 / DSM-5: β₯1 month of symptoms, impaired function, exclude organic/affective causes.
- Screen for organic mimics: temporal lobe epilepsy, substance misuse (cocaine, cannabis), brain tumour, thyroid disease.
- Psychiatric assessment: collateral history, mental state exam (MSE), risk assessment.
π Management
Medication
- π― First-line: Atypical antipsychotics (NICE CG178):
- Risperidone 2β6 mg/day.
- Olanzapine 10β20 mg/day (β οΈ metabolic risk).
- Quetiapine 300β600 mg/day.
- Aripiprazole 10β30 mg/day (less weight gain).
- π Typicals (e.g. haloperidol 2β10 mg/day) reserved if atypicals not tolerated.
- π Depot/long-acting injections for adherence problems.
- π©Έ Clozapine β ONLY for treatment-resistant schizophrenia (failed 2 other drugs).
- Start 12.5 mg BD β titrate to 300β450 mg/day.
- Monitor FBC weekly (risk: agranulocytosis, seizures, myocarditis).
π§ Psychosocial & Support
- π£οΈ CBT for psychosis (CBTp): helps manage hallucinations/delusions.
- π¨βπ©βπ¦ Family interventions: reduce relapse via psychoeducation & reducing expressed emotion.
- π Social support: supported housing, benefits advice, occupational rehab.
- π
Regular GP review: monitor weight, BP, HbA1c, lipids (antipsychotic SEs).
π₯ Crisis Care
- π¨ Admission if high suicide risk, danger to others, or unable to care for self.
- Rapid tranquillisation: IM haloperidol 2β5 mg + lorazepam 1β2 mg (NICE guidance).
β οΈ Monitor ECG (QTc), vitals, and airway.
π¨ Status Psychoticus (Refractory Agitation)
- Stepwise escalation: verbal de-escalation β oral meds β IM meds β seclusion as last resort.
- ECT considered in rare, severe catatonia or psychotic depression overlap.
π€° Schizophrenia in Pregnancy
- βοΈ Balance maternal stability with foetal safety.
- Olanzapine, quetiapine often used (relative safety data better than others).
- Clozapine β possible neonatal agranulocytosis, sedation: needs senior perinatal psychiatry input.
- Avoid valproate (teratogenic, not for women of childbearing age).
π Exam Pearls
- Positive = acute; Negative = chronic.
- Clozapine = gold standard in resistant schizophrenia.
- Always screen for suicide risk (10% lifetime risk).
- Donβt forget metabolic monitoring for all antipsychotics.
π References
Cases β Schizophrenia
- Case 1 β Positive symptoms π£οΈ: A 23-year-old man presents with a 6-month history of hearing voices commenting on his actions and believing neighbours are spying on him through the TV. He has withdrawn from university and stopped socialising. Mental state exam: third-person auditory hallucinations, persecutory delusions. Diagnosis: schizophrenia with prominent positive symptoms. Managed with an antipsychotic (first-line: oral atypical).
- Case 2 β Negative symptoms πΆ: A 28-year-old woman is brought by her family for social withdrawal, poor self-care, flat affect, and poverty of speech. She has no hallucinations but is unable to maintain work or relationships. Diagnosis: schizophrenia with predominant negative symptoms. Managed with antipsychotics and psychosocial interventions (CBT, supported employment).
- Case 3 β Relapse with poor adherence π: A 35-year-old man with a 10-year history of schizophrenia presents with recurrence of persecutory delusions after stopping his medication. He has previously responded well to risperidone but struggles with adherence. Diagnosis: schizophrenia relapse due to poor adherence. Managed with long-acting injectable antipsychotic (depot) and community psychiatric support.
Teaching Point π©Ί: Schizophrenia is a chronic psychotic disorder with positive symptoms (hallucinations, delusions, thought disorder) and negative symptoms (flattened affect, avolition, social withdrawal). Management combines antipsychotics, CBT for psychosis, family therapy, and community support. Non-adherence is a major cause of relapse.